Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in FTRE — Fortrea Holdings Inc.

CIK 820027 MINNEAPOLIS, MN
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$29,909,433
+$15,026,645 QoQ
Shares Held
1,718,933
+8.8% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. FTRE ranks #26 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,909,433 1,718,933
2026-03-31 $14,882,788 1,579,914
2025-12-31 $7,991,854 463,296
2025-09-30 $1,666,880 197,967
2025-06-30 $2,016,501 408,199
2025-03-31 $3,809,699 504,596
2024-12-31 $9,356,088 501,667
2024-09-30 $6,481,180 324,059
2024-06-30 $6,097,901 261,264
2024-03-31 $11,501,594 286,537
2023-12-31 $10,212,541 292,623
2023-09-30 $9,715,824 339,833